Excellent timeline. One question I'd be curious to hear your thoughts on: how much of the government's growing involvement do you think is driven by legitimate national security concerns versus broader industrial policy? A 30-day review window, for example, seems understandable from a security standpoint, but it also changes the relationship between government and frontier AI labs in interesting ways. I'd be interested in how you see that balance evolving.
Honestly I don't think you can separate them cleanly. The 30-day window is the same tool either way, whether you're worried about cyber capabilities leaking to an adversary or shaping which labs move fastest, you reach for the exact same lever. What tips it for me is the "trusted partners" language: reviewing a model is a security function, but deciding who gets early access is a competitive call, and that's industrial policy whether or not anyone calls it that.
That's a good distinction. Protecting against leaking capabilities and selecting trusted partners do seem to bleed together. There have been decades of concern over intellectual property theft and technology transfer, and the U.S. government has responded in ways that inevitably influence the market, including deciding who qualifies as a trusted partner. It's an ongoing competition where security objectives and industrial policy become difficult to separate. Considering how many technologies are now advancing at once, there's a great deal at stake, and much of it is deeply interconnected. Trying to strengthen security without overreaching is a genuinely difficult balance to strike.
Excellent timeline. One question I'd be curious to hear your thoughts on: how much of the government's growing involvement do you think is driven by legitimate national security concerns versus broader industrial policy? A 30-day review window, for example, seems understandable from a security standpoint, but it also changes the relationship between government and frontier AI labs in interesting ways. I'd be interested in how you see that balance evolving.
Honestly I don't think you can separate them cleanly. The 30-day window is the same tool either way, whether you're worried about cyber capabilities leaking to an adversary or shaping which labs move fastest, you reach for the exact same lever. What tips it for me is the "trusted partners" language: reviewing a model is a security function, but deciding who gets early access is a competitive call, and that's industrial policy whether or not anyone calls it that.
That's a good distinction. Protecting against leaking capabilities and selecting trusted partners do seem to bleed together. There have been decades of concern over intellectual property theft and technology transfer, and the U.S. government has responded in ways that inevitably influence the market, including deciding who qualifies as a trusted partner. It's an ongoing competition where security objectives and industrial policy become difficult to separate. Considering how many technologies are now advancing at once, there's a great deal at stake, and much of it is deeply interconnected. Trying to strengthen security without overreaching is a genuinely difficult balance to strike.